Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy

Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy

Abstract Background Emerging evidence has shown that intra-tumor immune features are associated with response to immune checkpoint blockade (ICB) therapy. Accordingly, patient stratification is needed for identifying target patients and designing strategies to improve the efficacy of ICB therapy. We...

Full description

Bibliographic Details
Main Authors: Jingkai Liu, Qiaofei Liu, Xiang Zhang, Ming Cui, Tong Li, Yalu Zhang, Quan Liao
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Cancer Cell International
Subjects:
Pancreatic cancer
Heterogeneity
Immune cell
Immune checkpoints
Immunotherapy
Transglutaminase 2
Online Access:https://doi.org/10.1186/s12935-021-01824-z

Similar Items

Similar Items